Zicom Group Ltd (ASX: ZGL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Zicom Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$21.56 million
P/E Ratio
2.84
Dividend Yield
0.00%
Shares Outstanding
215.58 million
Earnings per share
0.035
Dividend per share
N/A
Year To Date Return
-35.29%
Earnings Yield
35.22%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Zicom Group Ltd (ASX: ZGL)
Latest News
Share Market News
The Zicom Group (ASX:ZGL) share price shot up 128% today
Share Market News
ASX stock of the day: Zicom share price rockets 66% high on surgical mask investment
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 16 Mar 2017 | $0.0015 | 0.00% | Interim | 31 Mar 2017 |
| 29 Nov 2016 | $0.0020 | 0.00% | Final | 15 Dec 2016 |
| 16 Mar 2016 | $0.0025 | 0.00% | Interim | 31 Mar 2016 |
ZGL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Zicom Group Ltd
Zicom Group Ltd is engaged in engineering, procurement and construction of gas processing plants and compressor stations, design and supply of deck machinery, LNG propulsion systems, manufacturing of foundation equipment and concrete mixers, rental of foundation equipment, contract manufacturing of medical devices and full turnkey equipment, factory automation solutions and related parts and services. Its segments include Green Energy, Gas & Marine Equipment; Construction Equipment, and Precision Engineering & Technologies. Geographically, its operations are spread across Australia, Malaysia, Singapore, China, United States, Bangladesh, Thailand, New Zealand, Switzerland, Philippines, Others.
ZGL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 17 Apr 2026 | $0.10 | $-0.01 | -9.09% | 5,482 | $0.11 | $0.11 | $0.10 |
| 14 Apr 2026 | $0.11 | $0.00 | 0.00% | 25,000 | $0.11 | $0.11 | $0.11 |
| 13 Apr 2026 | $0.11 | $0.00 | 0.00% | 62,221 | $0.11 | $0.12 | $0.11 |
| 08 Apr 2026 | $0.11 | $0.00 | 0.00% | 2 | $0.11 | $0.11 | $0.11 |
| 07 Apr 2026 | $0.11 | $0.01 | 9.52% | 10,000 | $0.11 | $0.11 | $0.11 |
| 02 Apr 2026 | $0.11 | $0.00 | 0.00% | 49,276 | $0.11 | $0.11 | $0.11 |
| 31 Mar 2026 | $0.11 | $-0.01 | -9.09% | 11,159 | $0.11 | $0.11 | $0.11 |
| 30 Mar 2026 | $0.11 | $-0.01 | -8.70% | 24,077 | $0.12 | $0.12 | $0.11 |
| 27 Mar 2026 | $0.12 | $0.01 | 9.09% | 15,186 | $0.11 | $0.12 | $0.11 |
| 26 Mar 2026 | $0.11 | $0.00 | 0.00% | 21,010 | $0.11 | $0.11 | $0.11 |
| 25 Mar 2026 | $0.11 | $0.02 | 21.05% | 70,072 | $0.11 | $0.11 | $0.11 |
| 24 Mar 2026 | $0.10 | $-0.02 | -18.18% | 279,732 | $0.11 | $0.11 | $0.10 |
| 23 Mar 2026 | $0.11 | $0.00 | 0.00% | 203,983 | $0.11 | $0.11 | $0.11 |
| 20 Mar 2026 | $0.11 | $0.00 | 0.00% | 33,561 | $0.11 | $0.11 | $0.11 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 28 Nov 2025 | Giok Sim | Buy | 1,020,200 | $88,757 |
As advised by the company. Payment for bonus
|
| 29 May 2025 | Giok Sim | Buy | 306,044 | $25,323 |
On-market trade.
|
| 01 May 2025 | Giok Sim | Buy | 397,025 | $27,770 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Giok Lak Sim | Executive ChairmanExecutive Director | Apr 1995 |
Mr Sim was a board member of SPRING Singapore, a government agency for enterprise development, for 4 years until 2018 and a member of the Strategic Advisory Panel of Diagnostics Development Hub, A Star for 5 years until 2019. He was also a former member of the Board of Governors, UOB-SMU Asian Enterprise Institute. Experienced in public accounting, corporate development, strategic management as well as international trade.
|
| Mr Kok Hwee Sim | Alternate Director | Jul 2006 |
Mr Sim has experience in corporate and general management, engineering, treasury management, mergers and acquisitions and strategic partnerships.
|
| Mr Yian Poh Lim | Non-Executive Director | Jul 2006 |
Mr Lim has more than 20 years of experience in the banking and finance industry and is currently the managing director of Yian Poh Associates, a financial consultancy and investment firm. He has built a network of contacts, both in Singapore and in the region.
|
| Ms Jenny Bee Chun Lim | Executive DirectorJoint Company Secretary | Jun 2008 |
Ms Lim before joining the Group, was with an international public accounting firm for more than 10 years specialising in audit and tax.
|
| Mr Kok Yew Sim | Executive DirectorChief Executive Officer | Jul 2010 |
Mr Sim has been involved in Sys-Mac Group's growth journey, focusing on providing customised automation solutions, building capabilities and market penetration. He is involved directly in the ongoing transformation of the marine equipment sector to embrace green and clean energy applications.
|
| Mr Stewart Douglas | Non-Executive Director | Nov 2019 |
Mr Douglas is an Audit Partner/Director at Bentleys Queensland, an Australian national firm of public accountants. He has over 20 years of audit and professional experience in London, Singapore and Brisbane. He possesses expert technical knowledge across all facets of audit and assurance and across a range of sectors. He also brings along internal audit experience and has been responsible for many internal audits including internal control and governance reviews.
|
| Dr Dean Chi-Shang Tai | Non-Executive Director | Nov 2020 |
Dr Tai is a founder, chief scientific officer (CSO) and director of HistoIndex Pte. Ltd. (HistoIndex). HistoIndex is a medical technology company providing optical medical imaging systems and services to aid pathologists in diagnostics, clinical trials and research studies for the assessment and staging of liver diseases. He brings with him many years of board experience, global marketing exposure and collaborations in addition to his attributes in innovation, research and development.
|
| Mr Lim Sing En(Jonathan) | Non-Executive Director | Nov 2025 |
--
|
| Mr Gary Webster | Joint Company Secretary | Jul 2021 |
-
|
| Gary Webster | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Sns Holdings Pte Ltd | 94,028,360 | 43.82% |
| Citicorp Nominees Pty Limited | 17,039,074 | 7.94% |
| Gioklaksim | 14,479,303 | 6.75% |
| Finclear Services Pty Ltd | 9,429,573 | 4.39% |
| Mr Makram Hanna & Mrs Rita Hanna | 9,306,248 | 4.34% |
| Juat Lim Sim | 6,487,767 | 3.02% |
| Eegekgoh | 2,791,017 | 1.30% |
| Kailva Pty Ltd | 2,500,000 | 1.17% |
| Ms Shimin Sherlyn Ng | 2,423,165 | 1.13% |
| Juat Khiang Sim | 2,069,525 | 0.96% |
| BNP Paribas Nominees Pty Ltd | 2,009,159 | 0.94% |
| First Charnock Superannuation Pty Ltd | 1,890,000 | 0.88% |
| Zhang Hong Jun | 1,625,939 | 0.76% |
| Volms Pty Ltd | 1,621,075 | 0.76% |
| Mr Gordon James Mcmillan | 1,566,888 | 0.73% |
| Mr Aidan Hanna | 1,563,000 | 0.73% |
| Mr John Stephen Calvert | 1,557,196 | 0.73% |
| Kokhweesim | 1,488,180 | 0.69% |
| Kok Yew Sim | 1,350,253 | 0.63% |
| Mr Lachlan Donald Ashelford | 1,300,000 | 0.61% |
| Mr William James Oliver | 1,300,000 | 0.61% |